Últimas noticias sobre Himalaya Shipping (NYSE:HSHP) Bolsa

Himalaya Shipping Ltd is an independent dry bulk company that focuses on owning and operating its Newcastlemax dry bulk carriers.

Himalaya Shipping Ltd

HILL & SMITH HOLDINGS by Hill & Smith Holdings Plc.

Hill & Smith PLC

Macro Economic Events

News

Econ #s

Economics

USA Gasoline Inventories A Build Of 2.054M Barrels Vs A Draw Of 4.407M Barrels Prior

WIIM

QUBT

Quantum Computing shares are trading higher after the company announced it received a second order for its TFLN photonic chip foundry from the University of Texas.

USA EIA Weekly Distillates Stocks A Draw Of 0.114M Barrels Vs A Draw Of 1.394M Barrels Prior

Macro Notification

General

USA Crude Oil Inventories A Build Of 0.545M Barrels Vs  A Build Of 2.089M Barrels Prior

TransUnion's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRU#NYSE">TRU</a>) short percent of float has fallen 5.88% since its last report. The company recently reported that it has 4.35 million shares sold short, which is 2.24% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.47 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>TransUnion Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732116623_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for TransUnion has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing TransUnion's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, TransUnion's peer group average for short interest as a percentage of float is 2.95%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

(TRU) - Analyzing TransUnion's Short Interest

Kenvue's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>) short percent of float has risen 23.31% since its last report. The company recently reported that it has 38.50 million shares sold short, which is 2.01% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.3 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Kenvue Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732116617_0_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Kenvue has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Kenvue's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Kenvue's peer group average for short interest as a percentage of float is 5.61%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

KVUE

How Is The Market Feeling About Kenvue?

Reinsurance Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) short percent of float has fallen 8.06% since its last report. The company recently reported that it has 288 thousand shares sold short, which is 0.57% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Reinsurance Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732116612_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Reinsurance Gr has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Reinsurance Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Reinsurance Gr's peer group average for short interest as a percentage of float is 1.66%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Reinsurance Gr's Recent Short Interest

TD Cowen analyst Thomas Boyes maintains PureCycle Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) with a Buy and raises the price target from $10 to $15.

Price Target

Analyst Ratings

TD Cowen Maintains Buy on PureCycle Technologies, Raises Price Target to $15

DRMA

Dermata Therapeutics shares are trading higher after the company reported better-than-expected Q3 EPS results.

U.S. stocks were lower, with the Nasdaq Composite falling more than 200 points on Wednesday.
Shares of Williams-Sonoma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) rose sharply during Wednesday's session after the company reported <a href="https://www.benzinga.com/quote/WSM/earnings">better-than-expected third-quarter financial results.</a>
The company reported third-quarter adjusted earnings per share of $1.96, beating the analyst consensus of $1.78. Quarterly sales declined by 2.9% year-over-year to $1.8 billion, beating the street view of $1.79 billion. Comparable brand revenue was down 2.9% year-over-year.
Also, the company approved a $1 billion stock repurchase authorization.
Williams-Sonoma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) shares gained 22.7% to $168.48 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Red Cat Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) shares jumped 35.3% to $6.41. Palladyne AI and Red Cat expanded partnership for Teal Drones.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) shares surged 33.3% to $6.12. The company reported third-quarter earnings on Tuesday.</li>
<li>Alpha Teknova, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKNO#NASDAQ">TKNO</a>) rose 18.3% to $7.39.</li>
<li>Sunnova Energy International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) gained 18.2% to $4.0701.</li>
<li>Wix.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) gained 14.5% to $210.79 after the company reported better-than-expected third-quarter financial results and raised its FY24 revenue guidance. Also, multiple firms raised their respective price targets on the stock.</li>
<li>ATRenew Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NASDAQ">RERE</a>) gained 13.8% to $2.8000 following third-quarter results.</li>
<li>Global-E Online Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>) shares rose 10.5% to $47.24 after the company reported better-than-expected quarterly financial results and raised its FY24 revenue outlook.</li>
<li>HUTCHMED (China) Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCM#NASDAQ">HCM</a>) gained 10.1% to $18.44. HUTCHMED announced the appointment of independent non-executive director and member of board committee.</li>
<li>Dolby Laboratories, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) gained 9.9% to $77.96 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY25 EPS guidance above estimates.</li>
<li>Bruker Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRKR#NASDAQ">BRKR</a>) rose 9.2% to $52.69.</li>
<li>Azenta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZTA#NASDAQ">AZTA</a>) gained 9.2% to $44.68. Flex will replace Azenta in the S&amp;P MidCap 400, and Azenta will replace Envestnet in the S&amp;P SmallCap 600 effective prior to the opening of trading on Monday, Nov. 25.</li>
<li>Alignment Healthcare, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALHC#NASDAQ">ALHC</a>) gained 6.6% to $11.82.</li>
<li>Flex Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLEX#NASDAQ">FLEX</a>) gained 6.3% to $39.69.</li>
<li>Keysight Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEYS#NYSE">KEYS</a>) rose 5.2% to $160.02 after the company reported better-than-expected quarterly financial results. Also, multiple firms raised their respective price targets on the stock.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42086593/wall-streets-most-accurate-analysts-spotlight-on-3-financial-stocks-with-over-9-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Financial Stocks With Over 9% Dividend Yields</a></li>
</ul>

Intraday Update

Markets

Movers

ALHC

AZTA

BRKR

FLEX

GLBE

KEYS

NOVA

RCAT

RERE

TKNO

Williams-Sonoma, Wix.com, Dolby Laboratories And Other Big Stocks Moving Higher On Wednesday

TD Cowen analyst John Kernan maintains Amer Sports (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AS#NYSE">AS</a>) with a Buy and raises the price target from $21 to $23.

TD Cowen Maintains Buy on Amer Sports, Raises Price Target to $23

<a href="https://www.webull.com/">Webull</a>, a leading digital investment platform, today announced the expansion of its crypto futures offering with Coinbase Derivatives, LLC (Coinbase Derivatives), a futures exchange registered with the Commodity Futures Trading Commission (CFTC). Webull users in the U.S. will be able to trade futures contracts for Bitcoin (BTI), nano Bitcoin (BIT), Ethereum (ETI), and nano Ether (ET) directly on the Webull platform.
Webull launched futures and commodities trading in March 2024, which expands access and grants users the ability to further diversify their portfolios and manage risk more effectively. Webull will be bringing its advanced trading tools and Coinbase Derivatives' crypto futures offerings together for a seamless experience.

COIN

Webull Announces The Expansion Of Its Crypto Futures Offering With Coinbase Derivatives; Users In The U.S. Will Be Able To Trade Futures Contracts For Bitcoin (BTI), Nano Bitcoin (BIT), Ethereum (ETI), And Nano Ether (ET) Directly On The Webull Platform

Private equity billionaire Marc Rowan, who has emerged as a contender for the Treasury Secretary post, has openly admitted to being "out of my depth" when it comes to understanding cryptocurrency's role in the <a href="https://www.benzinga.com/trading-ideas/movers/24/11/42053981/trump-sec-pick-speculation-sends-this-altcoin-soaring-past-bitcoin-and-ethereum-in-daily-gains">U.S. financial system</a>.
What Happened: In a recent <a href="https://conversationswithtyler.com/episodes/marc-rowan/">podcast </a>with economist Tyler Cowen, the CEO of Apollo Global Management reflected on the complexities of cryptocurrency within the financial sector. 
Rowan criticized the limited understanding of crypto among prominent figures, including potential policymakers.
He said, "Out of my depth. Absolutely no idea," when asked directly about crypto's future role in the U.S. financial system.
Rowan further highlighted the potential for stablecoins and on-ramps to streamline the financial system but dismissed the relevance of alternative currencies in a regulated environment. 
"I see every opportunity for [stablecoins] to reduce the cost, to reduce the friction of dealing with the financial system," Rowan said.
However, he added, "In a KYC-AML world, I don't see a value for an alternative currency."
While Rowan was candid about his own lack of involvement in crypto through Apollo, his remarks raised questions about Warsh's readiness to tackle the growing importance of digital assets as a key component of financial policy.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42084945/coinbase-ceo-brian-armstrong-backs-doge-initiative-how-blockchain-could-transform-government-efficiency">Coinbase CEO Brian Armstrong Backs DOGE Initiative: How Blockchain Could Transform Government Efficiency</a>
Why It Matters: Prediction market Polymarket currently <a href="https://polymarket.com/event/who-will-trump-nominate-for-treasury-secretary">places</a> former Federal Reserve Governor Kevin Warsh as the leading candidate for the Treasury Secretary position, with a 50% chance.
Other contenders are hedge fund manager Scott Bessent (20%) and Rowan (20%). However, the volatile market reflects the participants&#8217; uncertainty, with Bessent&#8217;s and Rowan&#8217;s chances having traded above 50% in recent days.
Elon Musk also weighed in on the selection process, using his social media platform X to endorse Howard Lutnick, CEO of <a href="https://www.benzinga.com/etfs/24/11/42044642/trump-appears-frustrated-as-elon-musk-chimes-in-on-treasury-secretary-adds-more-names-to-a-list-of-potential-picks">Cantor Fitzgerald, for the position. </a>
While Lutnick was recently picked to lead the Commerce Department, Musk's public endorsement added another layer of speculation and reshaped the dynamics of the Treasury Secretary race.
Reports indicate that infighting among camps supporting Bessent and Lutnick has frustrated Trump, prompting him to consider alternatives. 
Rowan's candidacy has reportedly gained momentum following Lutnick's commerce appointment, while Bessent remains a strong competitor despite internal disputes.
The Treasury Secretary's role in shaping policies around these technologies will be critical as the U.S. faces growing competition from countries advancing their own <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40837533/put-in-the-cbdc-russian-central-bank-targets-july-2025-for-widespread-digital-ruble-use">central bank digital currencies (CBDCs)</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42072663/bitcoin-etf-options-could-smooth-volatility-become-available-on-robinhood-soon-expert-says">Bitcoin ETF Options Could Smooth Volatility, Become Available On Robinhood Soon, Expert Says</a></li>
</ul>
Image: Wikimedia

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Could Donald Trump's Potential Treasury Secretary Be 'Out Of His Depth' On Crypto Policy? Polymarket Traders Just Can't Decide On A Favorite

TD Cowen analyst Oliver Chen maintains Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) with a Buy and raises the price target from $90 to $100.

TD Cowen Maintains Buy on Walmart, Raises Price Target to $100

Endeavour Silver shares are trading lower. The company entered into an agreement to sell 15,825,000 units of common stock to a syndicate of underwriters led by BMO Capital for gross proceeds of approximately $73 million.

TD Cowen analyst Jared Levine maintains Trinet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNET#NYSE">TNET</a>) with a Buy and raises the price target from $92 to $104.

TNET

TD Cowen Maintains Buy on Trinet Group, Raises Price Target to $104

JFIN

Jiayin Group shares are trading lower after the company reported a year-over-year decrease in Q3 EPS results.

PDYN

Red Cat and Palladyne AI shares are trading higher after announcing a partnership expansion for teal drones.

XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) shares are trading slightly higher on Wednesday, following mixed third-quarter results from its rival, NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>).
NIO&#8217;s fiscal third quarter revenue totaled 18.67 billion yuan ($2.66 billion), down 2.1% year-over-year but up 7.0% from the previous quarter, missing the consensus estimate of $2.70 billion. The company posted an adjusted loss per share of 2.14 yuan (31 cents), a slight improvement from a <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/42084907/nio-q3-earnings-11-6-gain-in-vehicle-deliveries-margins-improve-issues-robust-q4-delivery-outlook" rel="noreferrer noopener">2.28 yuan loss in the same period last year.</a>
China&#8217;s $376 billion electric vehicle (EV) market continues to attract new entrants, including companies outside the traditional automotive sector, like makers of vacuum cleaners and hair dryers, according to a <a target="_blank" href="https://www.scmp.com/business/china-business/article/3286904/chinas-ev-market-lures-new-entrants-eyes-byds-crown-great-peril" rel="noreferrer noopener">report</a> from the South China Morning Post.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/emerging-markets/24/11/42068742/sony-eyes-japans-kadokawa-to-strengthen-gaming-and-anime-dominance" rel="noreferrer noopener">Sony Eyes Japan&#8217;s Kadokawa to Strengthen Gaming and Anime Dominance</a>
Despite optimism, the domestic EV market, the world&#8217;s largest, is projected to stagnate over the next two years in terms of revenue growth, the report read.
In contrast, XPeng is projecting robust fourth-quarter vehicle deliveries between 87,000 and 91,000, reflecting <a target="_blank" href="https://www.benzinga.com/24/11/42057872/xpeng-q3-earnings-over-18-topline-growth-deliveries-up-double-digit-percentage-margins-climb-over-15-ceo-eyes-ai-leadership" rel="noreferrer noopener">year-on-year growth of 44.6% to 51.3%</a>. The company also expects fourth-quarter revenue to range from 15.3 billion to 16.2 billion yuan, a year-on-year increase of 17.2% to 24.1%, surpassing the consensus estimate of 14.77 billion yuan.
XPeng&#8217;s flying car subsidiary, Xpeng Aeroht, made significant progress at the 15th China International Aviation and Aerospace Exhibition, securing 2,008 pre-orders for its <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/24/11/41946780/whats-going-on-with-xpeng-stock-wednesday" rel="noreferrer noopener">modular flying car, the Land Aircraft Carrier</a>.
Despite these developments, XPeng&#8217;s stock has dropped over 30% in the past year. Investors seeking exposure to XPeng can access the stock through the SPDR S&amp;P Kensho Smart Mobility ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAIL#NYSE">HAIL</a>).
Price Action: XPEV shares are trading higher by 2.04% to $12.78 at last check Wednesday.
Photo via Shutterstock
Also Read:
<ul>
<li><a href="https://www.benzinga.com//node/42082386" target="_blank" rel="noreferrer noopener">Tesla&#8217;s Chinese Rival Xpeng Vows To &#8216;Do Whatever It Takes To Be Competitive&#8217; Amid Donald Trump&#8217;s Tariff Threat</a></li>
</ul>

Equities

Media

HAIL

XPEV

What's Going On With XPeng Stock Today?

Whales with a lot of money to spend have taken a noticeably bearish stance on Microsoft.
Looking at options history for Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 30% of the investors opened trades with bullish expectations and 50% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $468,781 and 5, calls, for a total amount of $513,015.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $200.0 to $480.0 for Microsoft during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Microsoft's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Microsoft's substantial trades, within a strike price spectrum from $200.0 to $480.0 over the preceding 30 days.
<h3>Microsoft 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732115900_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$224.55</td>
<td>$222.65</td>
<td>$224.55</td>
<td>$200.00</td>
<td>$314.2K</td>
<td>173</td>
<td>4</td>
</tr>
<tr>
<td>MSFT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$82.95</td>
<td>$78.45</td>
<td>$81.17</td>
<td>$480.00</td>
<td>$121.7K</td>
<td>18</td>
<td>15</td>
</tr>
<tr>
<td>MSFT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$7.75</td>
<td>$7.75</td>
<td>$7.75</td>
<td>$410.00</td>
<td>$109.2K</td>
<td>7.5K</td>
<td>16</td>
</tr>
<tr>
<td>MSFT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$4.95</td>
<td>$4.8</td>
<td>$4.93</td>
<td>$415.00</td>
<td>$98.7K</td>
<td>3.1K</td>
<td>1.0K</td>
</tr>
<tr>
<td>MSFT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$16.95</td>
<td>$16.75</td>
<td>$16.95</td>
<td>$365.00</td>
<td>$81.3K</td>
<td>999</td>
<td>0</td>
</tr>
</tbody>
</table>

<h3>About Microsoft</h3>
Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).
Having examined the options trading patterns of Microsoft, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Microsoft</h3>
<ul>
<li>Trading volume stands at 2,124,214, with MSFT's price down by -1.1%, positioned at $413.2.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 69 days.</li>
</ul>
<h3>Expert Opinions on Microsoft</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $508.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Microsoft with a target price of $600. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Microsoft, which currently sits at a price target of $465. 
&#x2A; Maintaining their stance, an analyst from Bernstein continues to hold a Outperform rating for Microsoft, targeting a price of $500. 
&#x2A; An analyst from TD Cowen has decided to maintain their Buy rating on Microsoft, which currently sits at a price target of $475. 
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Microsoft, which currently sits at a price target of $500. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Microsoft with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

MSFT

Decoding Microsoft's Options Activity: What's the Big Picture?

In a report released on June 20, Peter M. E. Christensen from Cleaves Securities maintained a Hold rating on Himalaya Shipping Ltd. (HSHP – Researc...

Cleaves Securities Remains a Hold on Himalaya Shipping Ltd. (HSHP)

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
While <a href="https://investorplace.com/stock-types/blue-chip-stocks/">blue chip stocks</a> are always a good investment portfolio idea, I suggest some smart diversification. And one of the best ways that I know to diversify is to buy highly rated stocks under $10.



Stocks under $10 may not sound interesting, but these names can be a strategic move for anyone wanting to diversify and improve their portfolios. 



While cautious investors will associate lower-priced stocks with higher risk, the Portfolio Grader can help you find some outstanding choices to round out a portfolio.



It&rsquo;s important to remember that stocks under $10, when included in a portfolio of blue-chip equities, can expose you to smaller companies with high growth potential. And diversification is important because if you have a falling segment, your gains from other sectors can help you mitigate your losses.



The Portfolio Grader can help you find stocks that are priced low, not because they are struggling but because they are an excellent opportunity. Stocks under $10 could be priced that way because of restructuring or because the company is in an emerging industry.



By evaluating stocks based on momentum, analyst sentiment, revenue growth and earnings performance, you have a better chance of choosing quality stocks under $10 for your portfolio. These seven names are a good place to start.



<h2>Summit Therapeutics (SMMT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/bio1600-300x169.jpg" alt="MRNA Stock Will Continue Its Slump, but a $25 It Will Be a Great Buy"><div>Source: Shutterstock</div></div>Summit Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/smmt-stock-quote/">SMMT</a>) is a biopharmaceutical company that works on the discovery, development and commercialization of therapies for unmet medical needs.



The company currently has two Phase 3 trials underway with its lead candidate, ivonescimab, an investigational bispecific antibody to treat non-small cell lung cancer.



The company recently raised <a href="https://www.smmttx.com/wp-content/uploads/2024/06/2024_PR_0602_Fundraise-and-Expansion-of-Summit-License-Territories-for-Ivonescimab-_-FINAL.pdf">$200 million</a> from an institutional investor for 22.2 million shares of SMMT stock. It plans to use the money to advance the development of ivonescimab, with the goal of completing Phase 3 trials and submitting the treatment to regulators for approval.



That money will be added to the <a href="https://www.smmttx.com/pressrelease/summit-therapeutics-reports-financial-results-and-operational-progress-for-the-first-quarter-ended-march-31-2024/">$157 million</a> the company had on hand at the end of the first quarter, in which it spent $46.2 million on operating expenses. The company doesn&rsquo;t have an income stream yet, so it posted a loss of $34 million, or 5 cents per share, for the first quarter.



SMMT stock is up 196% in 2024 and gets a &ldquo;B&rdquo; rating in the Portfolio Grader.



<h2>Annexon (ANNX)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/biotech1600d-300x169.jpg" alt="Image of two scientists in lab coats studying results in a lab. best biotech stocks to buy"><div>Source: Shutterstock</div></div>Annexon (NASDAQ:<a href="https://investorplace.com/stock-quotes/annx-stock-quote/">ANNX</a>) is a California-based bioscience company developing treatments for autoimmune, neurodegenerative, and ophthalmic diseases of the body, brain, and eye.



Its impressive pipeline includes a potential treatment for Guillain-Barre syndrome, a rare disorder in which the body&rsquo;s immune system is expected to report Phase 3 trials in the fourth quarter.



It also has Phase 2 trials for potential treatments for geographic atrophy, Huntington&rsquo;s disease and amyotrophic lateral sclerosis, otherwise known as ALS.



<a href="https://ir.annexonbio.com/news-releases/news-release-details/annexon-reports-first-quarter-2024-financial-results-and-key">Earnings for the first quarter</a> included $21 million in research and development expenses and $7.6 million in administrative costs. The company has cash and cash equivalents of $264.9 million and expects to have enough money currently to fund operations into mid-2026.



ANNX stock is up 14% this year and gets a &ldquo;B&rdquo; rating in the Portfolio Grader.



<h2>Aurora Cannabis (ACB)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/aurora-cannabis-stock-3-300x169.jpg" alt="aerial view of a cannabis plant in a pot. cannabis stocks"><div>Source: Shutterstock</div></div>Aurora Cannabis (NASDAQ:<a href="https://investorplace.com/stock-quotes/acb-stock-quote/">ACB</a>) is a Canadian cannabis company that is considered a leading producer of medical cannabis in Canada.



The company has a variety of medical-use and adult recreational products, including flower products, vapes, edibles, concentrates and more.



<a href="https://investorplace.com/industries/healthcare/cannabis/">Cannabis stocks</a> were a hot commodity in 2020 when there was an expectation that the Biden administration and a Democratic-controlled Congress would push through federal legalization of marijuana rather than leaving it to the states. 



However, the Covid-19 pandemic and inflationary issues derailed those plans, and federal recreational use is still a pipe dream for Aurora investors.



However, the Justice Department is recommending that cannabis be reclassified from a Schedule 1 to a Schedule 3 drug, which would give marijuana stocks a boost.



<a href="https://www.auroramj.com/press-releases/article/?id=123076">Aurora&rsquo;s financial results for the fourth quarter of fiscal 2024</a> (ending March 31) included $67.4 million in revenue, up 5% from the previous year. Medicinal cannabis made up a large part of that increase, as it was up 20% from last year, while adult recreational use was down 29%.



I expect the numbers for adult recreational cannabis to improve. ACB stock is up 15% this year and gets a &ldquo;B&rdquo; rating in the Portfolio Grader.



<h2>Himalaya Shipping (HSHP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/zim_shipping1600-2-300x169.png" alt="A large ULCV container ship underway, sails on open water fully loaded with containers and cargo - the ZIM San Francisco"><div>Source: ImagineStock / Shutterstock.com</div></div>Based in Bermuda, Himalaya Shipping (NYSE:<a href="https://investorplace.com/stock-quotes/hshp-stock-quote/">HSHP</a>) is a new entrant into the shipping business. It just accepted delivery of its 12th dual-fueled dry bulk vessel from a Chinese shipyard, with each ship capable of transporting 210,000 in dead weight tonnage.



As new ships, the fleet of next-generation cargo ships can use liquefied natural gas for propulsion, reducing per-ton emissions by 60%. The company also started paying a monthly dividend in January, and plans to continue the practice that will be popular for income investors.



Earnings for the first quarter of 2024 included revenue of $23.6 million and net income of $2.5 million. Now that the fleet is fully operational, Himalaya Shipping should see those numbers improve.



HSHP stock is up 27% in 2024 and gets an &ldquo;A&rdquo; rating in the Portfolio Grader.



<h2>Emergent BioSolutions (EBS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/08/ebs-stock-1-300x169.jpg" alt="A mobile phone displays the website for Emergent Biosolutions (EBS)"><div>Source: T. Schneider / Shutterstock.com</div></div>Emergent BioSolutions (NYSE:<a href="https://investorplace.com/stock-quotes/ebs-stock-quote/">EBS</a>) is a biopharmaceutical company headquartered in Maryland. The company develops vaccines and antibody therapies for infectious diseases and to treat opioid overdoses.



The company has countermeasures to combat some of the most critical public health threats in the world, including smallpox, anthrax and botulism. It also makes a reactive skin decontamination lotion kit among other products.



Meanwhile, its pipeline includes potential treatments for Lassa fever, Ebola, and influenza.



The company is undoubtedly doing important work, and it&rsquo;s being well rewarded. <a href="https://investors.emergentbiosolutions.com/static-files/6f3b9a75-7d44-4585-a6b6-65c067219850">Revenues</a> in the first quarter were $300.4 million, up from $164.3 million in the same quarter a year ago. The company also posted a profit of $9 million after posting a loss of $186.2 million in the first quarter of 2023.



&nbsp;EBS stock is on a roll this year, up 169% so far. It gets a &ldquo;B&rdquo; rating in the Portfolio Grader.



<h2>Reborn Coffee (REBN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/09/coffee_1600-300x169.jpg" alt="NUZE Stock. A photo of a cup of coffee and some coffee beans and a towel on a wooden table. Coffee stocks"><div>Source: Evgeny Karandaev/ShutterStock.com</div></div>Reborn Coffee (NASDAQ:<a href="https://investorplace.com/stock-quotes/rebn-stock-quote/">REBN</a>) is a specialty coffee maker. Coffee is one of the most popular drinks in the U.S., with an estimated <a href="https://www.statista.com/topics/9899/coffee-consumption-trends-in-the-united-states/">73%</a> of American consumers acknowledging being a coffee drinker. 



It seems there&rsquo;s coffee for every pallet, including high-priced coffeehouse drinks to at-home drip coffee makers that give you a basic cup of joe.



Reborn Coffee is has only 14 locations, mostly in California. But it also offers a subscription service on its website, and makes whole-bean products, pour-over packs and cold brew packs.



It doesn&rsquo;t expect to stay small for long. Reborn announced an <a href="//www.pressviewer.com/profiles/investor/NewsPrint.asp?v=7&amp;b=2799&amp;ID=135032&amp;m=rl&amp;g=2317%27,%27LibDiv%27);">expansion</a> into China and Southeast Asia and plans to open a location in Abu Dhabi. It also has serious <a href="//www.pressviewer.com/profiles/investor/NewsPrint.asp?v=7&amp;b=2799&amp;ID=135157&amp;m=rl&amp;g=2317%27,%27LibDiv%27);">e-commerce</a> plans by making its products available on Amazon (NASDAQ:<a href="https://investorplace.com/stock-quotes/amzn-stock-quote/">AMZN</a>).



Earnings for the <a href="https://www.reborncoffee.net/news-events/press-releases/#b2iLibScrollTo">fourth quarter of 2023</a> included revenue of $1.8 million, up 109% from the same quarter a year ago. Full-year revenue was $6 million versus $3.2 million in 2022.



REBN stock is up 48% this year and gets a &ldquo;B&rdquo; rating in the Portfolio Grader.



<h2>NuScale Power (SMR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/03/smr1600-300x169.png" alt="Person holding smartphone with logo of US nuclear power company NuScale Power LLC on screen in front of website. Focus on phone display. Unmodified photo. SMR stock"><div>Source: T. Schneider / Shutterstock.com</div></div>NuScale Power (NYSE:<a href="https://investorplace.com/stock-quotes/smr-stock-quote/">SMR</a>) is an Oregon company that makes small modular light water nuclear reactors that are expected to help companies phase out coal-powered plants.



The company also is seeking approval for a proposal in Romania that would be the first European project to use small modular light nuclear reactor technology. The effort has $4 billion in commitments for U.S. financial institutions, and the company is hoping to get approval in 2025.



Such a deal would be a massive win for NuScale and its investors.



SMR stock, which has reactors that can provide power in nuclear plants, is under $10 now but probably won&rsquo;t be for long. It is currently up 190% in 2024 and gets a &ldquo;B&rdquo; rating in the Portfolio Grader.



On the date of publication, neither Louis&nbsp;Navellier nor the InvestorPlace Research Staff member primarily responsible for this article held (either directly or indirectly) any positions in the securities mentioned in this article.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/market360/2024/06/7-top-stocks-under-10-june-2024-edition/">7 Top Stocks Under $10: June 2024 Edition</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Top Stocks Under $10: June 2024 Edition

In a report released on July 8, Peter M. E. Christensen from Cleaves Securities maintained a Hold rating on Himalaya Shipping Ltd. (HSHP – Research...

Himalaya Shipping Ltd. (HSHP) Receives a Rating Update from a Top Analyst

Himalaya Shipping Ltd. raises dividend by 25% to $0.05

Himalaya Shipping Ltd. raises dividend by 20% to $0.06

Himalaya Shipping: Potential In Ton-Mile Demand, But Overvalued And Overleveraged

Himalaya Shipping Ltd. dividend raises by 16.7% to $0.07

Himalaya Shipping Ltd. declares $0.10 dividend

Himalaya Shipping: Speculative Bet On Strong Capesize Market

Himalaya Shipping declares $0.04 dividend

AMZN

ANNX

HSHP

REBN

SMMT

Capital Clean Energy Carriers Corp. - Common Share

Capital Clean Energy

Costamare Inc. Common Stock $0.0001 par value

Costamare

Castor Maritime

Danaos

Diana Shipping

EuroDry

Euroseas

Globus Maritime

Genco Shipping & Trading Limited Ordinary Shares New (Marshall Islands)

Genco Shipping & Trading

Golden Ocean Group Limited - Common Stock

Golden Ocean Group

Global Ship Lease Inc New Class A Common Shares

Global Ship Lease

Himalaya Shipping

Caravelle International Group - Ordinary Shares

Caravelle Intl Gr

Kirby

Lakeside Holding

Matson

Navios Maritime Partners LP Common Units Representing Limited Partner Interests

Navios Maritime Partners

Pangaea Logistics Solutions Ltd. - Common Stock

Pangaea Logistics Solns

Performance Shipping Inc. - Common Shares

Performance Shipping

Pyxis Tankers

Safe Bulkers, Inc Common Stock ($0.001 par value)

Safe Bulkers

Star Bulk Carriers

Seanergy Maritime Holdings Corp. - Common Stock

Seanergy Maritime Hldgs

Toro

United Maritime Corporation - Common Stock

United Maritime

ZIM Integrated Shipping Services Ltd. Ordinary Shares

Comments

Himalaya Shipping

Noticias

Últimas noticias sobre Himalaya Shipping (NYSE:HSHP) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL